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ABSTRACT 
_________________________________________________________________ 
In the present study, three biologically active, substituted acyl thiourea compounds (1–3) have 
been synthesized from 2,4-dichlorobenzoyl chloride, potassium thiocyanate and the 
corresponding secondary amine in dry acetone. The synthesized compounds were characterized 
by elemental analyses, UV–Visible, FT-IR, 1H & 13C NMR spectroscopic techniques. The 
molecular structures of 1–3 were determined by single crystal X-ray crystallography which 
shows twists of up to 70º about the (S=)C–NC(=O) bonds. All the synthesized compounds show 
good antioxidant and anticancer potential, in particular, compound 2 derived from di-n-
propylamine. 
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Introduction 
 The significance of acylthiourea derivatives has been investigated for over a century and 
their results have proven diverse applications of acylthioureas in various fields. Thiourea 
derivatives have widely been used in analytical and process chemistry applications [1]. For the 
liquid–liquid extraction and pre-concentration of platinum group metals, N,N-dialkyl-N′-
acylthioureas were used as ionophores [2]. Transition-metal complexes comprising  
N,N-dialkyl-N′-acylthioureas ligands acted as effective catalysts in oxidation catalysis [3-6]. 
Many corrosion studies confirmed the corrosion prevention ability of acylthioureas on the 
surface of a wide range of metals in different corrosive environments [7–9]. Acylthioureas  
are convenient synthons for the preparation of versatile heterocyclic compounds through 
cyclization [10,11]. Particularly relevant to the present investigation is that thiourea derivatives 
are well known for their biological activities such =as antimicrobial [12,13], antifungal [14], 
antibacterial [15], insecticidal [16], herbicidalactivity [17], etc. Polysubstituted acylthiourea and 
its fused heterocycle derivatives were utilized as inhibitors of influenza virus [18]. In addition, 
acylthiourea derivatives and their coordination compounds exhibit strong antitumor and 
anticancer activity [19]. Benzoylphenylthiourea derivatives possess potent antitumor activity 
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against both pancreatic and prostate cancer cell lines [20]. Thiourea derivatives bearing 
benzothiazole moiety have been used as powerful anticancer agents [21]. We report herein the 
synthesis and X-ray crystallographic studies of three new derivatives, namely 2,4-dichloro-N-
(diphenylcarbamothioyl)benzamide (1), 2,4-dichloro-N-(dipropylcarbamothioyl)benzamide (2) 
and 2,4-dichloro-N-(dibutylcarbamothioyl)benzamide (3) and their in vitro antioxidant and 
anticancer studies. 
 
Experimental 
Materials and methods 
 All chemicals used in this work were procured from commercial sources and utilized 
without further purification. The organic solvents were distilled and purified according to 
literature procedures. Elemental analyses were performed by a Vario EL AMX-400 elemental 
analyzer. Uncorrected melting points were obtained in open capillary tubes on a Sigma melting 
point apparatus. FT-IR spectra in the mid-IR region (4000–600 cm-1) were recorded on a Nicolet 
iS5 FT-IR spectrophotometer with KBr pellets. UV-vis spectra in the range 800 to 200 nm were 
recorded in ethanol solutions using a PG Instruments double-beam UV-vis spectrophotometer 
(Model T90+) with a quartz cell of 1 cm path length. 1H and 13C NMR spectra were recorded on 
BrukerAvance 400 MHz instrument in DMSO-d6 with TMS as an internal standard. 
 
Synthesis  
A solution of 2,4-dichlorobenzoyl chloride (1.0473 g, 5 mmol) in acetone (50 mL) was 
added drop wise to a suspension of potassium thiocyanate (0.4859 g, 5 mmol) in anhydrous 
acetone (50 mL). The reaction mixture was heated under reflux for 45 minutes and then cooled 
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to room temperature. A solution of diphenyl amine / di-n-propyl amine / di-n-butyl amine 
(0.5059–0.8461 g, 10 mmol) in acetone (30 mL) was added and the resulting mixture was stirred 
for 2 h at room temperature. Hydrochloric acid (0.1 N, 500 mL) was added and the resulting 
white solid was filtered off, washed with water and dried in vacuo.  Single crystals of 1-3 for X-
ray diffraction studies were grown at room temperature from their respective dichloromethane 
solutions. 
 
Synthesis of 2,4-dichloro-N-(diphenylcarbamothioyl)benzamide (1) 
Yield: 90%. Orange solid. m.p. 162 oC. Anal. Calc. for C20H14Cl2N2OS (%): C, 59.86;  
H, 3.52; N, 6.98; S, 7.99. Found: C, 59.80; H, 3.51; N, 6.94; S, 7.94. UV [Ethanol, λ in nm  
(ε in dm3mol-1cm-1)]: 220 (98,247), 317 (37,216). FT–IR (KBr): ν = 3162 (N–H), 1691 (C=O), 
1261 (C=S) cm-1. 1H NMR (DMSO-d6): δ 11.42 (s, 1H, N–H), 7.02–7.74 (m, 13H, aromatic) 
ppm. 13C NMR (DMSO-d6): δ 183.2 (C=S), 161.7 (C=O), 117.1, 120.1, 127.4, 127.5, 127.7, 
129.6, 129.7, 130.7, 131.5, 132.1, 133.6, 134.4, 136.0, 136.1, 145.8 (aromatic) ppm. 
 
Synthesis of 2,4-dichloro-N-(dipropylcarbamothioyl)benzamide (2) 
Yield: 85%. White solid. m.p. 153 oC. Anal. Calc. for C14H18Cl2N2OS (%): C, 50.45;  
H, 5.44; N, 8.41; S, 9.62. Found: C, 50.41; H, 5.42; N, 8.37; S, 9.58. UV [Ethanol, λ in nm  
(ε in dm3mol-1cm-1)]: 207 (30,240), 286 (8,522). FT–IR (KBr): ν = 3230 (N–H), 1661 (C=O), 
1210 (C=S) cm-1. 1H NMR (DMSO-d6): δ 10.90 (s, 1H, N–H), 7.46–7.69 (m, 3H, aromatic), 3.85 
(t, 2H, CH2), 3.54 (t, 2H, CH2), 1.65–1.75 (m, 4H, CH2), 0.85 (t, 3H, CH3), 0.92 (t, 3H, CH3) 
ppm. 13C NMR (DMSO-d6): δ 179.8 (C=S), 163.2 (C=O), 127.8, 129.7, 130.7, 131.8, 134.8, 
135.6 (aromatic), 54.2, 54.6 (CH2), 19.5, 21.7 (CH2), 11.4, 11.5 (CH3) ppm. 
5 
 
 
Synthesis of 2,4-dichloro-N-(dibutylcarbamothioyl)benzamide (3) 
 
Yield: 88%. White solid. m.p. 157 oC. Anal. Calc. for C16H22Cl2N2OS (%): C, 53.18;  
H, 6.14; N, 7.75; S, 8.87. Found: C, 53.11; H, 6.11; N, 7.70; S, 8.81. UV [Ethanol, λ in nm  
(ε in dm3mol-1cm-1)]: 206 (15,085), 287 (4,432). FT–IR (KBr): ν = 3186 (N–H), 1678 (C=O), 
1238 (C=S) cm-1. 1H NMR (DMSO-d6): δ 10.87 (s, 1H, N–H), 7.46–7.71 (m, 3H, aromatic), 3.88 
(t, 2H, CH2), 3.56 (t, 2H, CH2), 1.58–1.71 (m, 4H, CH2), 1.58–1.71 (m, 4H, CH2), 0.86–0.93 (m, 
6H, CH3) ppm. 13C NMR (DMSO-d6): δ 179.7 (C=S), 163.1 (C=O), 127.8, 129.7, 130.7, 131.8, 
134.7, 135.7 (aromatic), 52.8, 52.4 (CH2), 30.3, 28.2 (CH2), 20.0, 19.9 (CH2), 14.2, 14.0 (CH3) 
ppm. 
 
X-ray crystallography 
Intensity data for 1–3 were measured at 100 K on a Agilent Technologies SuperNova Dual CCD 
with an Atlas detector using CuKα radiation, λ = 1.54184 Å [22].  The structures were solved by 
direct methods (SHELXS97 [23] through the WinGX Interface [24]) and refined (anisotropic 
displacement parameters, C-bound H atoms in the riding model approximation and a weighting 
scheme of the form w = 1/[σ2(Fo2) + aP2 + bP] where P = (Fo2 + 2Fc2)/3) with SHELXL2014/7 
on F2 [25].  The N-bound hydrogen atoms were located from difference maps and refined with 
N–H = 0.88±0.01 Å.  In the refinement of 1, the chloride atom at the C4 position of molecule ‘a’ 
was disordered over the C4/C8 positions.  The major component had a site occupancy factor = 
0.850(3).  The analyzed sample was a two-component twin [twin law: -1 0 0, 0 -1 0, 0.721 0 1] 
and the minor component fraction was 0.3905(6).  In the final refinement, 14 reflections with 
poor agreement were omitted.  In the refinement of 3, both molecules exhibited disorder in the 
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C4-bound chloride atoms.  The major components had site occupancy factors = 0.8667(17) and 
0.9379(18) for molecules ‘a’ and ‘b’, respectively.  One of the n-butyl groups was also found to 
be disordered so that the C14 and C15 atoms were located over two positions; major component 
= 0.740(6).  The molecular structure diagrams shown in Fig. 1 were drawn with 70% 
displacement ellipsoids [24], and overlay diagrams, also in Fig. 1, were drawn in QMol [26].  
Crystallographic data are collated in Table 1.  The crystal packing diagrams were generated with 
DIAMOND [27] with additional crystallographic analysis employing PLATON [28]. 
 
 
Table 1 
Summary of the crystallographic data for 1–3. 
 1 2 3 
Formula C20H14Cl2N2OS C14H18Cl2N2OS C16H22Cl2N2OS 
Formula weight 401.29 333.26 361.31 
Crystal size (mm) 0.08 x 0.14 x 0.16 0.08 x 0.18 x 0.28 0.05 x 0.15 x 0.18 
Crystal system monoclinic monoclinic monoclinic 
Space group P21/c P21/c P21/n 
a/Å 13.2182(2) 13.33360(10) 18.1370(4) 
b/Å 14.3820(4) 23.7506(2) 9.66110(10) 
c/Å 39.3125(6) 9.90310(10) 21.3995(3) 
α/° 90 90 90 
β/° 96.965(2) 91.0180(10) 106.520(2) 
γ/° 90 90 90 
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V/Å3 7418.3(3) 3135.63(5) 3594.91(11) 
Z/Zꞌ 16/4 8/2 8/2 
Dc/g cm–3 1.437 1.412 1.335 
µ/mm–1 4.294 4.942 4.351 
θ range/° 3.3–77.5 3.3–77.3 2.8–77.6 
Reflections measured 69016 26241 38181 
Independent reflections; Rint 21284, 0.050 6594, 0.027 7576, 0.036 
Reflections with I > 2σ(I) 19129 6286 6646 
Number of parameters 960 371 447 
R, obs. data; all data 0.041, 0.046 0.027, 0.028 0.038, 0.044 
a; b in wght scheme 0.051; 7.608 0.040; 1.692 0.053; 2.356 
Rw, obs. data; all data 0.108, 0.110 0.070, 0.071 0.097, 0.102 
GoF (F2) 1.05 0.95 1.04 
∆ρmax, min (e Å–3) 0.79, -0.64 0.36, -0.38 0.54, -0.30 
 
 
Antioxidant activity 
Phosphomolybdate assay 
The antioxidant activity of 1–3 was evaluated according to the method of Prieto et al. 
[29]. An aliquot of 100 µl of compounds was combined with 1 ml of reagent solution (0.6 M 
sulphuric acid, 28 mM sodium phosphate, and 4 mM ammonium molybdate) in a screw-capped 
vial. The vials were closed and incubated in a water bath at 95 °C for 90 min. After the samples 
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had cooled to room temperature, the absorbance of the mixture was measured at 695 nm against 
a blank. The results expressed as ascorbic acid equivalent antioxidant activity. 
 
Ferric reducing power 
The reducing power of the synthesized acythiourea derivatives was determined according 
to the method of Oyaizu [30]. Samples (2.5 ml) in phosphate buffer (2.5 ml, 0.2 M, pH 6.6) were 
added to potassium ferricyanide (2.5 ml, 1.0%) and the mixture was incubated at 50 °C for 20 
min. Trichloroacetic acid (2.5 ml, 10%) was added, and the mixture was centrifuged at 650 x g 
for 10 min. The supernatant (5.0 ml) was mixed with ferric chloride (5.0 ml, 0.1%), and then the 
absorbance was read spectrophotometrically at 700 nm. Based on the absorbency value, the 
ferric reducing power of compounds was expressed. 
 
DPPH radical scavenging activity 
The DPPH radical scavenging activity was analyzed for each compound by following 
method of Sanchez-Moreno et al. [31]. The compounds (100 µl) was added to 3.9 ml of DPPH 
solution (0.025 g/L) and the reactants were incubated at 25 °C for 30 min. Different 
concentrations of ferulic acid was used as a positive control and ethanol was used instead of 
compounds in the blank (control). The decrease in absorbance was measured at 515 nm using a 
spectrophotometer. The radical scavenging activity of tested samples was calculated and 
expressed on percentage basis. 
 
Superoxide radical scavenging activity 
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 The capacity of prepared compounds to scavenge the superoxide anion radical was 
measured according to the method described by Zhishen et al. [32]. The reaction mixture was 
prepared using 3 x 10-6 M riboflavin, 1 x 10-2 M methionine, 1 x 10-4 M nitroblue tetrozolium 
chloride and 0.1 mM EDTA in phosphate buffered saline (pH 7.4). For the analysis, 3.0 ml of the 
reaction mixture was taken with 100 µl of compounds in closed tubes and illuminated for 40 min 
under fluorescent lamp (18 W). The absorbance was then read at 560 nm against the un-
illuminated reaction mixture. Results were expressed as superoxide radical scavenging activity 
on a percentage basis. 
 
Cytotoxicity 
The anticancer potentialy of acylthiourea compounds was evaluated in the EAC cell line. 
The EAC cells were obtained from Swiss mice after 15 days of cancer induction. The peritoneal 
fluid containing EAC cells was collected aseptically using a 5 ml syringe and cultured in 
Dulbecco’s modified Eagle’s medium supplemented with 10% heat-inactivated foetal bovine 
serum, 1% nonessential amino acids, and 1% penicillin (5000 IU/mL)-streptomycin (5000 
L/mL) solution at 37 °C under 5% CO2 atmosphere. Initially the cells were washed with PBS 
twice, centrifuged and the cell pellet was collected and re-suspended in DMEM medium and 
incubated at 37 °C for 2 days in a CO2 incubator.  
The anticancer effects of 1–3 was analyzed by treating with EAC cells for 24 h and the 
cell viability will be checked using MTT assay [33]. After attaining 60% confluency, the cells 
were trypsinized and dispersed in 96 well plate with a cell count of 9000 cells per well and 
incubated for 24 h. Then the compounds were added at different concentration and then again 
incubated for 24 h. At the end, the medium was discarded, cells are washed with PBS and 20 
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micro liter of MTT reagent was added in each well and incubated for 6 h at 37 ºC in a water bath. 
Then 150 micro liter of acidic isopropanol was added and shaken for 30 min on a plate shaker 
under dark. The absorbance was measured at 540 nm and the percentage of cell viability was 
calculated and from that the cytotoxic was derived. 
 
Results and discussion 
Synthesis 
Compounds 1–3 were synthesized from 2,4-dichlorobenzoyl chloride, potassium 
thiocyanate and the corresponding secondary amine in dry acetone (Scheme 1). The compound 1 
is orange while remaining compounds (2 and 3) are white. The synthesized compounds are air-
stable and non-hygroscopic in nature, soluble in organic solvents such as n-hexane, ethyl acetate, 
acetone, acetonitrile, benzene, dichloromethane, chloroform, DMSO and DMF, and insoluble in 
water. The analytical data obtained are in good agreement with the proposed molecular formulae. 
 
Spectroscopy 
The synthesized acylthiourea compounds showed two bands around 206–220 and  
286–317 nm in their UV-vis spectra, which are ascribed to pi–pi* and n–pi* transitions, 
respectively. The FT–IR spectra of all the compounds exhibited very strong absorption bands 
around 3162–3230 cm-1 which suggest the presence of N–H group in their structures. The 
observation of a strong band in the region 1661–1691 cm-1 and a medium intensity band in the 
region 1210–1261 cm-1 in the FT–IR spectra of 1–3 confirmed the presence of  
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Scheme 1. Synthesis of acyl thiourea compounds. 
 
C=O and C=S groups, respectively [5]. The 1H NMR spectra showed a singlet around 
10.87−11.42 ppm, which has been attributed to the N−H proton of ligands. The multiplets 
observed in the region 7.02−7.74 ppm, in the 1H NMR spectra of all the compounds, have been 
assigned to the aromatic protons of the phenyl ring(s) present in the compounds. In addition, 1H 
NMR spectrum of 2 showed two triplets at 3.85 and 3.54 ppm and a multiplet at 1.65−1.75 ppm, 
which were assigned to the methylene protons, and two triplets around 0.85 and 0.92 ppm which 
have been attributed to the terminal methyl protons. The duplication of the resonances are 
consistent with the non-equivalence of the n-propyl groups in solution; similar duplicity was 
noted for 3.  Thus, two triplets appeared at 3.56 and 3.88 ppm in the 1H NMR spectrum of 3 due 
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to the protons of methylene groups which are proximate to nitrogen. 1H NMR spectrum of 3 also 
exhibited two multiplets in the region 1.23−1.37 and 1.58−1.71 ppm, which were attributed to 
the remaining methylene protons of the aliphatic chain. A multiplet (merging of two triplets) at 
0.86−0.93 ppm was assigned to the methyl protons. In the 13C NMR spectra of 1–3 the signals 
observed around 128.3−146.4 ppm were assigned to the aryl carbons and signals appeared in the 
regions at 179.7−183.2 and 161.7−163.2 ppm  have been ascribed to C=S and C=O carbons, 
respectively. 
 
X-ray crystallography 
The molecular structures of 1–3 have been established by single crystal X-ray 
crystallography, Fig. 1.  All three compounds present multiple molecules in their respective 
crystallographic asymmetric units, i.e. four in 1 (molecules ‘a’, ‘b’, ‘c’, and ‘d’) and two in each 
of 2 and 3 (molecules ‘a’ and b’).  Selected geometric parameters for 1-3 are collected in Table 
2.  The thione residue in 1 is flanked on either side by diphenyl amine and amide groups.  The 
C1–N1 bond lengths are systematically longer than the C1–N2 bonds, Table 1.  There are also 
systematic trends in the bond angles subtended at the C1 atom that are related to steric effects.  
Thus, while the S1–C1–N1 angle is close to 120º, the S1–C1–N2 angle is significantly wider, by 
about 5º, to relieve steric stress between the doubly bonded sulfur atom and disubstituted amine 
group, and this is compensated by a smaller angle subtended by the N1 and N2 atoms, Table 2.  
A similar situation pertains to the angles about the C2 atom with the O1–C1–N1 angles being 8-
9º wider than the N1–C2–C3 angles, Table 1.  The C1–N1–C2–O1 residues are co-planar with 
the maximum deviation, i.e. 5.9(5)º, noted for molecule ‘d’.  However, twists of up to 60º are 
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noted about the C1–N1 bond as manifested in the S1–C1–N1–C2 and N2–C1–N1–C2 torsion 
angles, and twists in the range 30-40º are seen about the C2–C3 bonds. 
 
Fig. 1.  (a) Molecular structures of the four independent molecules comprising the asymmetric 
unit of 1, and overlay diagram showing molecules a (red image), b (green), c (blue) and inverted 
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d (pink), (b) the two independent molecules of 2 and overlay diagrams of molecules a (red 
image) and b (blue), and (c) the two independent molecules of 3 and overlay diagrams of 
molecules a (red image) and inverted b (blue).  Only the major component of the disorder is 
shown in each case.  For the overlay diagrams, the molecules have been overlapped so the N2S 
atoms are coincident. 
 
The same trends are noted in the C1–N1 vs C1–N2 bond lengths in 2 as for 1 (and 3).  
Twists of up 12º are noted about the C1–N2 bond, Table 2, and greater twists are noted in the 
S1–C1–N1–C2 torsion angles, i.e. 65º.  While the N1–C2–C3–C4 torsion angle in 2 are about the 
same as the equivalent angles in 1, greater twists, again ca. 65º, are noted in the N2–C1–N1–C2 
torsion angles.  The substitution of n-propyl groups in 2 for n-butyl in 3 does not have a 
chemically significant impact upon the molecular geometries, with differences in torsion angles 
being less than 2º. 
 
Geometric parameters characterizing the molecular packing in 1–3 are summarized in 
Table 3.  The most prominent feature of the molecular packing of 1 is the formation of amine-N-
H…S(thione) hydrogen bonds between molecules of ‘a’ and ‘d’, Fig. 2a, between 
centrosymmetrically related molecules of ‘b’, and between centrosymmetrically related 
molecules of ‘c’, giving rise to three distinct eight-membered {…HNCS}2 synthons.  These are 
connected into supramolecular layers by C–H…Cl, C–H…O, involving all four independent 
carbonyl-O atoms, and C–H…S interactions.  Layers stack along the c-axis enabling inter-
digitation of the chlorophenyl rings.  Layers are connected by C–Cl…pi(phenyl) and C–
S…pi(chlorophenyl) interactions to consolidate the three-dimensional crystal, Fig. 2b. 
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Table 2 
Selected geometric data (Å, º) for 1–3. 
 1a 1b 1c 1d 2a 2b 3a 3b 
C1–S1 1.667(3) 1.656(3) 1.655(3) 1.662(3) 1.6773(13) 1.6752(13) 1.6812(17) 1.6821(18) 
C1–N1 1.393(3) 1.403(3) 1.409(4) 1.404(3) 1.4251(16) 1.4168(16) 1.417(2) 1.419(2) 
C1–N2 1.351(4) 1.341(4) 1.354(4) 1.347(4) 1.3242(16) 1.3290(17) 1.325(2) 1.327(2) 
C2–O1 1.213(4) 1.218(4) 1.212(4) 1.219(4) 1.2279(16) 1.2204(16) 1.220(2) 1.221(2) 
S1–C1–N1 120.0(2) 120.4(2) 120.2(2) 120.0(2) 117.99(9) 117.62(9) 118.29(12) 117.63(12) 
S1–C1–N2 123.9(2) 124.6(2) 125.2(2) 123.8(2) 125.47(10) 125.55(10) 125.21(13) 126.22(14) 
N1–C1–N2 116.1(3) 115.0(3) 114.6(3) 116.2(2) 116.53(11) 116.83(11) 116.48(15) 116.15(15) 
O1–C2–N1 123.7(3) 122.6(3) 123.2(3) 123.0(3) 122.95(11) 123.32(12) 122.95(16) 123.47(16) 
O1–C2–C3 121.0(3) 121.3(3) 120.5(3) 120.4(3) 119.84(11) 120.59(12) 120.18(15) 120.39(16) 
N1–C2–C3 115.2(2) 116.0(3) 116.2(3) 116.5(2) 117.16(11) 116.08(11) 116.84(14) 116.11(15) 
S1–C1–N1–C2 -133.6(3) -121.3(3) -125.2(3) 131.5(3) 114.66(11) 115.27(12) -110.73(16) 112.65(16) 
C1–N1–C2–O1 -3.0(5) 0.0(4) -2.4(5) 5.9(5) 11.54(18) 8.68(19) -12.9(3) 12.3(3) 
N1–C2–C3–C4 49.0(4) 40.3(4) 47.1(4) -49.5(4) -46.72(17) -46.54(17) 46.5(2) -49.6(2) 
N2–C1–N1–C2 48.0(4) 60.9(4) 56.5(4) -49.0(4) -65.86(15) -65.25(16) 68.0(2) -67.0(2) 
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Table 3 
Summary of intermolecular interactions (Å, º) in 1–3. 
 
 A H D H…D A…D A-H…D Symmetry operation 
1 
 N1a H1a S1d 2.47(2) 3.331(2) 168(3) -1+x, y, z 
 N1b H1b S1b 2.48(3) 3.323(2) 160(2) -x, 1-y, 1-z 
 N1c H1c S1c 2.59(3) 3.384(3) 151(3) 1-x, 1-y, -z 
 N1d H1d S1a 2.52(2) 3.399(2) 173(3) 1+x, y, z 
 C8b H8b Cl1c 2.79 3.734(3) 172 x, 1½-y, ½+z 
 C8c H8c Cl1b 2.69 3.565(3) 153 x, ½-y, -½+z 
  C11b H11b O1c 2.58 3.406(5) 146 x, ½-y, ½+z 
 C13a H13a O1d 2.51 3.272(3) 137 x, y, z 
 C13b H13b O1b 2.30 3.159(4) 150 1-x, 1-y, 1-z 
 C13c H13c O1c 2.58 3.265(4) 130 -x, 1-y, -z 
 C13d H13d O1a 2.56 3.361(4) 142 x, y, z 
 C19a H19a S1b 2.84 3.778(4) 171 -x, -½+y, ½-z 
 C6b Cl2b Cg(C9a-C14a) 3.5380(14) 5.082(3) 147.13(10) x, ½-y, ½+z 
 C1b S1b Cg(C3b-C8b) 3.6972(13) 5.235(3) 153.83(11) -x, 1-y, 1-z 
 C1c S1c Cg(C3c-C8c) 3.6912(14) 5.262(3) 158.08(11) 1-x, 1-y, -z 
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2 
 N1a H1a S1a 2.652(15) 3.5121(11) 170.2(13) 1-x, 1-y, 2-z 
 N1b H1b O1a 2.156(15) 3.0216(14) 176.3(13) x, y, z 
 C10b H10c Cl1a 2.68 3.5893(15) 152 x, y, -1+z 
 C5b H5b Cg(C3a-C8a) 2.76 3.4466(13) 129 1-x, 1-y, 1-z 
3 
 N1a H1a S1b 2.576(10) 3.4542(15) 176(2) x, -1+y, z 
 N1b H1b S1a 2.534(11) 3.3939(15) 168(2) x, 1+y, z 
 C7a H7a S1a 2.87 3.8008(19) 168 x, 1+y, z 
 C7b H7b S1b 2.77 3.709(2) 170 x, -1+y, z 
 C13a H13b O1a 2.50 3.384(2) 149 ½-x, -½+y, ½-z 
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Fig. 2.  (a) Two molecule aggregate sustained by an eight-membered {…HNCS}2 synthon in 1, 
(b) view in projection down the b-axis of the unit cell contents for 1, (c) four-molecule aggregate 
in 2 mediated by the {…HNCS}2 synthon and amide-N–H…O(carbonyl) hydrogen bonds, (d) 
view in projection down the c-axis of the unit cell contents for 2, and (e) view in projection down 
the b-axis of the unit cell contents for 3.  The N–H…S hydrogen bonds are shown as blue dashed 
lines.  In (b), the C–H…Cl, O and S interactions are shown as orange dashed lines while the C–
Cl…pi(phenyl) and C–S…pi(chlorophenyl) interactions are shown as pink and purple dashed 
lines, respectively.  In (d) the N–H…O hydrogen bonds and C–H…Cl and C–H…pi interactions 
are shown as orange, brown and purple dashed lines, respectively.  In (e) the C–H…O and C–
H…S interactions are shown as orange and brown dashed lines, respectively.  In (d) and (e) the 
inter-layer Cl…Cl halogen bonding (see text) is not shown. 
 
In the crystal of 2, amine-N–H…S(thione) hydrogen bonding between 
centrosymmetrically related molecules of ‘a’ leads to the formation eight-membered {…HNCS}2 
synthons, as for 1.  The second independent molecule associates with the dimer via amide-N–
H…O(carbonyl) hydrogen bonding leading to a four molecule aggregate, Fig. 2c, Table 3.  These 
are connected into slabs that stack along the b-axis via C–H…Cl and C–H…pi(chlorophenyl) 
interactions.  The most significant inter-layer interactions appear to be halogen bonding.  While 
the Cl2a…Cl2bi separations of 3.5686(6) Å are greater than the sum of the van der Waals radii, 
i.e. 3.50 Å, the crystal contains chloride-rich channels so that the interactions reinforce each 
other, Fig. 2d; symmetry operation i: 1-x, 1-y, 1-z. 
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In 3, the two independent molecules associate via {…HNCS}2 synthons, to form two-
molecule aggregates, Table 3.  These are connected into supramolecular layers via a combination 
of C–H…S and C–H…O interactions, Fig. 2e.  Connections between layers along the a-axis are 
again halogen bonding, i.e. Cl1a…Cl1ai = 3.2450(7) Å; symmetry operation i: 1-x, -y, 1-z. 
 
Antioxidant activity 
Reactive oxygen species (ROS) are produced in the body as a result of incomplete 
reduction of oxygen during oxidative phosphorylation [34]. Free radicals can attack DNA and 
results in mutation and cancer [35]. Free radicals can also react with proteins, carbohydrates and 
lipids and plays a significant role in the pathogenesis of numerous disorders and patho-
physiological processes including cardiovascular diseases, diabetes, and cancer [36]. Oxidative 
stress occurs, when the system loses its ability to neutralize the excessively produced reactive 
species. The redox homeostasis, i.e. the balance between the free radicals and antioxidants is 
necessary for maintaining good health. This balance is maintained by a number of antioxidants 
(vitamin E and ascorbic acid) and enzymes like catalase, glutathione peroxidise, glutathione-S-
transferase, superoxide dismutase, etc. Under severe conditions, above-mentioned antioxidant 
system is not sufficient to prevent the oxidative stress. Hence, intake of external anti-oxidants is 
necessary for maintaining homeostasis in the body. In this connection, several attempts have 
been made to synthesize molecules and their derivatives with effective antioxidant property in 
the past [20,21,37,38]. In the present study also, we have evaluated the antioxidant activity of the 
three amine acyl thiourea derivatives, 1–3, as summarized in Fig. 3. 
In the phosphomolybdate assay, molybdenum(VI) is reduced to molybdenum(V) by an 
antioxidant to forms a green complex at acidic pH in the presence of phosphorous with an 
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absorption maxima at 695 nm. This assay evaluates the reducing or electron donating power of 
the antioxidant to molybdenum with the intensity of phosphomolybdate (PMo(V)) complex 
being proportional to antioxidant power of the extract. The reducing capacity of the trial 
compound may serve as a significant indicator of its potential antioxidant ability. Among the 
presently analyzed compounds, 2 recorded a higher level of phosphomolybdate reducing power 
in dose-dependent manner, Fig. 3a. In the ferric reducing assay, iron(III) is reduced to iron(II) by 
the antioxidant compound through electron transfer. The reduced iron(II) forms the Pearl’s blue 
complex, which can be measured at 700 nm. Fig. 3b reveals the ferric reducing power of 
presently investigated compounds and that 2 registered the maximum ferric reducing activity 
when compared to the other two compounds. 
DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable radical, the methanolic solution of 
which is dark-purple with a maximum absorption at 515 nm. The evaluation of the antioxidant 
power by DPPH radical scavenging activity has been widely used for different plant extracts and 
synthetic compounds. Antioxidants can reduce DPPH through hydrogen transfer into its non-
radical form (DPPH-H) and hence the absorption disappears at 515 nm. The decrease in 
absorbency at 515 nm may be due to the reaction between phytochemicals and DPPH, which 
indicates the antioxidant power. In the present study, 2 recorded the highest DPPH radical 
scavenging activity, which is followed by 3 and 1, Fig. 3c. 
Superoxide radical is an oxygen molecule with one unpaired electron. Superoxide is 
biologically quite toxic and is deployed by the immune system to kill invading microorganisms. 
In phagocytes, superoxide is produced in large quantities by the enzyme NADPH oxidase for use 
in oxygen-dependent killing mechanisms of invading pathogens. Although the superoxide anion 
is a weak oxidant, it gives rise to the generation of powerful and dangerous hydroxyl radicals as 
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well as singlet oxygen, both of which contribute to the oxidative stress. The superoxide radical 
scavenging activity of samples was investigated by generating superoxide through photo-induced 
reduction of riboflavin, which can generate superoxide radical in the presence of methionine. 
The generated superoxide radical reduce the NBT into purple formazan, which was evaluated at 
560 nm. In presence of antioxidant, the generated superoxide radicals were scavenged and hence, 
formation of purple formazan is minimal or nil. The superoxide radical scavenging activity of the 
synthesized compounds is represented in Fig. 3d with …give summary of the key result(s)… 
 
Anticancer activity 
 Cancer is often associated with increased risk of death and the toxic side effects caused 
by the modern medicine, many cancer patients seek alternative and complementary methods of 
treatment such as usage of phytomedicine [39]. At present chemotherapy is considered as the 
most efficient approach for cancer treatment. Even though it significantly improves symptoms 
and the quality of life of cancer patients, only modest increases in survival rate can be achieved. 
As a palliative care, many cancer patients use herbal therapies. Medicinal plants are well known 
for their free radical scavenging and antioxidant activities [40]. Free radical attack results in the 
oxidative damage of various biomolecules including lipids, proteins and DNA. The damage 
caused in DNA leads to mutation or cancer, which is the most dangerous effect in human beings. 
Plants contain phytochemicals with strong antioxidant activities which may prevent and control 
cancer and other diseases by protecting the cells from the deleterious effects of the free radicals. 
In the present time researchers are focusing their research towards the development of eco-
friendly anticancer drugs, which resulted in the development of novel chemotherapeutic agents 
such as paclitaxel, vincristine, podophyllotoxin, and camptothecin. 
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 The newly synthesized acylthiourea derivatives 1–3 were screened for anticancer 
potential against Ehrlich Ascites Carcinoma (EAC) cell lines employing the MTT assay with a 
view to develop a natural and safe anticancer drug. Among the compounds tested, 2 revealed 
remarkable level of anticancer effect, Fig. 4. Cytotoxicity was found to be at a maximum even at 
very low concentrations, and the death of the cells caused by the test compound might be due to 
the loss of mitochondria [41]. From the MTT assay, it is evident that the cytotoxicity of the 
extracts against EAC cell line was dose dependent. 
 Similar to the present study, Hallur et al. reported the anticancer activity of 
benzoylphenylurea sulfur analogues in breast, pancreatic and propstate cancer cell lines [20].  
Saeed et al. also evaluated the anticancer activity of some thiourea derivatives bearing 
benzothiazole moiety in MCF-7 and Hela cell lines [21]. Further, the cytotoxic effect of 
nickel(II) complexes synthesized using the 3,3-dialkyl/aryl-1-(2,4-dichlorobenzoyl) thiourea 
ligands has been investigated in human lung cancer (A549) and colon cancer cell lines (HT29) 
[37]. Based on the results obtained from the present study, 2 was found to be more effective in 
controlling the growth of EAC cell lines when compared to other extracts. Hence, it could be 
considered as a source of potential anticancer drug and further in vivo models must be used to 
explore the potential of this compound for clinical use. 
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Fig. 3.  Antioxidant activity of synthesized compounds: (a) phosphomolybdate reducing power, 
(b) Ferric reducing power, (c) DPPH radical scavenging activity, and (d) superoxide radical 
scavenging activity. 
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Fig. 4.  Anticancer activity of 1–3 against the EAC cancer cell line. 
 
Conclusions 
 In summary, three acylthiourea derivatives, 1–3, were prepared and characterized by 
analytical and spectral methods.  Three dimensional structures of all three compounds were 
derived by single crystal X-ray crystallography. The acylthiourea derivatives were subjected to 
in vitro antioxidant and anticancer studies. The results indicated that 2 is more effective in 
exhibiting antioxidant and anti-cancer properties when compared to other compounds. This 
might be due to the steric effect of the molecule through which it could activate the functional 
groups and exhibited the remarkable antioxidant and anticancer potentials. On the other hand, the 
low levels of antioxidant and anticancer activities of other two compounds (1 and 3) might be 
due to the hindrance effects, which might down-regulate the effect of functional groups. Hence, 
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based on the preliminary study, the 2 was selected for further study as it shows promising 
antioxidant and anticancer activities. Further details research is necessary to investigate the 
anticancer potential of this compound in suitable animal model and also to reveal the mechanism 
of action / pathway through which 2 induces apoptosis and effectively arrest the cell 
proliferation. 
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